Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3443 of 6351
-
Can a diabetes drug and special diet boost chemo for pancreatic cancer?
Disease control OngoingThis pilot phase I trial studies the side effects of gemcitabine hydrochloride, nab-paclitaxel, metformin hydrochloride, and a standardized dietary supplement in treating patients with pancreatic cancer that cannot be removed by surgery. Drugs used in chemotherapy, such as gemcit…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Exercise and education may offer drug-free relief for hand osteoarthritis
Symptom relief CompletedThis study will investigate outcomes of a 3-month first-line treatment program for hand osteoarthritis, using data from the Swedish Osteoarthritis Registry.
Sponsor: Lund University • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
New malaria vaccine for pregnant women enters human testing
Vaccine CompletedThe primary objective of the study is to evaluate the safety of 3 different dosages (20µg - 50µg and 100µg) of a placental malaria vaccine candidate (PRIMVAC vaccine) adjuvanted either with Alhydrogel® or GLA-SE, and administered at D0, D28 and D56 in healthy European and Burkina…
Phase 1 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Vaccine
Last updated Jun 27, 2026 08:00 UTC
-
New molecular test could spot heart transplant rejection faster
Knowledge-focused Recruiting nowDemonstrate the impact of the Molecular Microscope Diagnostic System as the standard of care for heart transplant patients.
Sponsor: University of Alberta • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Could a cancer drug boost radiation for rare sarcomas?
Disease control CompletedA phase Ib study of Olaparib with concomitant radiotherapy in locally advanced/unresectable soft-tissue sarcoma.
Phase 1 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Skin electricity may foresee dementia outbursts
Knowledge-focused CompletedIt is generally acknowledged that patients with dementia are best cared for at home. However, outbursts of various behavioral disturbances, e.g., combativeness, appear in most cases and often necessitate institutionalization. These outbursts are often without apparent warning, wh…
Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
New cancer drug shows promise in early trial for Tough-to-Treat tumors
Disease control CompletedA Phase 1/2a, dose-escalation study of FF-10502-01 in Patients with Advanced Solid Tumors and Lymphomas. A total of up to 9 cohorts will be enrolled in Phase 1 to establish the Maximum Tolerated Dose (MTD). Phase 2 will consist of 2 cohorts: Cohort 1 will include subjects with Pa…
Phase 1/2 • Sponsor: Fujifilm Pharmaceuticals U.S.A., Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New device aims to stop deadly infections in tiny preemies
Prevention Stopped earlyThis study evaluates the potential interest of a new multi-lumen infusion access device (Edelvaiss® Multiline NEO) in the prevention of catheter-related bacteremia when administering injectable drugs in premature infants. This device will be compared to the standard infusion set …
Sponsor: University Hospital, Lille • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Targeted drug regorafenib tested in rare thyroid cancer
Disease control CompletedThis research study is studying a targeted therapy as a possible treatment for thyroid cancer. A targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific types of cancer cells with less harm to normal cells. \- The name of the s…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Gene therapy tackles HIV and lymphoma in one shot
Disease control OngoingThis pilot clinical trial studies gene therapy after frontline chemotherapy in treating patients with acquired immune deficiency syndrome (AIDS)-related non-Hodgkin lymphoma (NHL). Placing genes for anti-human immunodeficiency virus (HIV) ribonucleic acid (RNA) into stem/progenit…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Experimental combo targets Hard-to-Treat cancers
Disease control CompletedThis study will assess the safety, tolerability, and pharmacokinetics of AZD1775 (adavosertib) given orally in combination with intravenous MEDI4736 (durvalumab). Secondly, the immunogenicity, pharmacodynamics, and preliminary anti-tumour activity will be determined in patients w…
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New digital scope aims to spot bile duct cancer more accurately
Diagnosis OngoingDifferentiation between malignant and benign biliary strictures can be challenging. Accurate differentiation of malignant biliary strictures from benign ones is crucial to guide management decisions. While conventional tissue acquisition techniques such as brush cytology or intr…
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
New imaging agent could light up brain tumors
Diagnosis Recruiting nowThis pilot trial studies the side effects of hyperpolarized carbon C 13 pyruvate magnetic resonance imaging (MRI) in diagnosing participants with glioma. Diagnostic procedures, such as hyperpolarized carbon C 13 pyruvate MRI, may help find and diagnose glioma.
Phase 1 • Sponsor: Susan Chang • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Liver scan may predict deadly failure after big operations
Knowledge-focused CompletedExtended hepatectomies of 4 or more segments are complicated by high rates of morbidity and mortality, mainly related to hepatic liver failure. Nowadays, preoperative assessment of the future remnant liver is just performed through its volumetric measurement by computed tomograph…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Massive ethiopian trial tests hygiene vs. antibiotics for blinding eye disease
Knowledge-focused CompletedSWIFT I is a series of 3 cluster-randomized trials designed to assess several alternative strategies for trachoma control in communities that have been treated with many years of mass azithromycin distributions. The first trial (named WUHA) compares communities that receive a com…
Phase 3 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Hands-On healing: osteopathy tested for fibromyalgia relief
Symptom relief CompletedThe purpose of this study is to evaluate the analgesic effects of a 6 weeks osteopathic treatment on patients with fibromyalgia.
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 26, 2026 13:50 UTC
-
Blood RNA clues may predict heart failure outcomes
Knowledge-focused OngoingThe primary objective is to measure the association between extracellular RNA (ex-RNA) levels in plasma in patients receiving aggressive outpatient therapy for CHF with (1) cardiac remodeling and (2) cardiovascular events. The investigators will follow patients during standard me…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Brain scan may sharpen tumor treatment choices
Knowledge-focused Completed18F-FDOPA PET is expensive. It is mandatory therefore to assess its impact on the management of patients with high-grade gliomas in order to provide medico-economic justification for its use. The article by the UCLA group showed that 18F-FDOPA modified 41% of management decisions…
Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Promising combo for prostate cancer halted early
Disease control Stopped earlyThis phase Ib/II trial studies the safety, side effects, best dose, and effectiveness of ribociclib when given with enzalutamide in treating patients with castrate-resistant prostate cancer that has spread from the primary site (place where it started) to other places in the body…
Phase 1/2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Extra oxygen may boost exercise in lung disease patients
Symptom relief CompletedThe purpose is to determine if patients with idiopathic pulmonary fibrosis (IPF) taking nintedanib will have improved exercise endurance, breathlessness and quality of life if breathing 60% oxygen compared to standard of care during an 8 week exercise training program.
Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC